REIT - Residential
Compare Stocks
2 / 10Stock Comparison
VRE vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
VRE vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Residential | REIT - Healthcare Facilities |
| Market Cap | $1.78B | $151.66B |
| Revenue (TTM) | $291M | $11.63B |
| Net Income (TTM) | $70M | $1.43B |
| Gross Margin | 23.4% | 39.1% |
| Operating Margin | 14.7% | 4.4% |
| Forward P/E | 23.7x | 79.7x |
| Total Debt | $1.37B | $21.38B |
| Cash & Equiv. | $14M | $5.03B |
VRE vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Veris Residential, … (VRE) | 100 | 124.6 | +24.6% |
| Welltower Inc. (WELL) | 100 | 427.2 | +327.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VRE vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VRE carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 3 yrs, beta 0.22, yield 1.7%
- Lower P/E (23.7x vs 79.7x)
- 24.2% margin vs WELL's 12.3%
WELL is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 233.9% 10Y total return vs VRE's -12.8%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs VRE's 6.4% | |
| Value | Lower P/E (23.7x vs 79.7x) | |
| Quality / Margins | 24.2% margin vs WELL's 12.3% | |
| Stability / Safety | Beta 0.13 vs VRE's 0.22, lower leverage | |
| Dividends | 1.7% yield, 3-year raise streak, vs WELL's 1.3% | |
| Momentum (1Y) | +45.8% vs VRE's +21.7% | |
| Efficiency (ROA) | 2.5% ROA vs WELL's 2.3%, ROIC 1.3% vs 0.5% |
VRE vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VRE vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
WELL leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 40.0x VRE's $291M. VRE is the more profitable business, keeping 24.2% of every revenue dollar as net income compared to WELL's 12.3%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $291M | $11.6B |
| EBITDAEarnings before interest/tax | $129M | $2.8B |
| Net IncomeAfter-tax profit | $70M | $1.4B |
| Free Cash FlowCash after capex | $50M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +23.4% | +39.1% |
| Operating MarginEBIT ÷ Revenue | +14.7% | +4.4% |
| Net MarginNet income ÷ Revenue | +24.2% | +12.3% |
| FCF MarginFCF ÷ Revenue | +17.1% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.5% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -36.4% | +22.5% |
Valuation Metrics
VRE leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 23.7x trailing earnings, VRE trades at a 85% valuation discount to WELL's 155.7x P/E. On an enterprise value basis, VRE's 23.1x EV/EBITDA is more attractive than WELL's 67.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.8B | $151.7B |
| Enterprise ValueMkt cap + debt − cash | $3.1B | $168.0B |
| Trailing P/EPrice ÷ TTM EPS | 23.69x | 155.73x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 79.69x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 23.08x | 67.37x |
| Price / SalesMarket cap ÷ Revenue | 6.17x | 14.22x |
| Price / BookPrice ÷ Book value/share | 1.52x | 3.40x |
| Price / FCFMarket cap ÷ FCF | 32.35x | 53.25x |
Profitability & Efficiency
VRE leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
VRE delivers a 5.6% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $3 for WELL. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRE's 1.07x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +5.6% | +3.5% |
| ROA (TTM)Return on assets | +2.5% | +2.3% |
| ROICReturn on invested capital | +1.3% | +0.5% |
| ROCEReturn on capital employed | +2.0% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 |
| Debt / EquityFinancial leverage | 1.07x | 0.49x |
| Net DebtTotal debt minus cash | $1.4B | $16.3B |
| Cash & Equiv.Liquid assets | $14M | $5.0B |
| Total DebtShort + long-term debt | $1.4B | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | 1.84x | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,193 today (with dividends reinvested), compared to $11,436 for VRE. Over the past 12 months, WELL leads with a +45.8% total return vs VRE's +21.7%. The 3-year compound annual growth rate (CAGR) favors WELL at 43.3% vs VRE's 6.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +28.2% | +16.2% |
| 1-Year ReturnPast 12 months | +21.7% | +45.8% |
| 3-Year ReturnCumulative with dividends | +21.4% | +194.0% |
| 5-Year ReturnCumulative with dividends | +14.4% | +211.9% |
| 10-Year ReturnCumulative with dividends | -12.8% | +233.9% |
| CAGR (3Y)Annualised 3-year return | +6.7% | +43.3% |
Risk & Volatility
Evenly matched — VRE and WELL each lead in 1 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than VRE's 0.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.22x | 0.13x |
| 52-Week HighHighest price in past year | $19.03 | $219.59 |
| 52-Week LowLowest price in past year | $13.69 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +99.6% | +98.6% |
| RSI (14)Momentum oscillator 0–100 | 65.1 | 57.6 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 2.6M |
Analyst Outlook
VRE leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates VRE as "Hold" and WELL as "Buy". Consensus price targets imply 4.6% upside for WELL (target: $227) vs -26.1% for VRE (target: $14). For income investors, VRE offers the higher dividend yield at 1.70% vs WELL's 1.28%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $14.00 | $226.50 |
| # AnalystsCovering analysts | 12 | 34 |
| Dividend YieldAnnual dividend ÷ price | +1.7% | +1.3% |
| Dividend StreakConsecutive years of raises | 3 | 2 |
| Dividend / ShareAnnual DPS | $0.32 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | 0.0% |
VRE leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). WELL leads in 2 (Income & Cash Flow, Total Returns). 1 tied.
VRE vs WELL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is VRE or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 6. 4% for Veris Residential, Inc. (VRE). Veris Residential, Inc. (VRE) offers the better valuation at 23. 7x trailing P/E, making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VRE or WELL?
On trailing P/E, Veris Residential, Inc.
(VRE) is the cheapest at 23. 7x versus Welltower Inc. at 155. 7x.
03Which is the better long-term investment — VRE or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +211. 9%, compared to +14. 4% for Veris Residential, Inc. (VRE). Over 10 years, the gap is even starker: WELL returned +233. 9% versus VRE's -12. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VRE or WELL?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 13β versus Veris Residential, Inc. 's 0. 22β — meaning VRE is approximately 67% more volatile than WELL relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 107% for Veris Residential, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VRE or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 6. 4% for Veris Residential, Inc. (VRE). On earnings-per-share growth, the picture is similar: Veris Residential, Inc. grew EPS 420. 0% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VRE or WELL?
Veris Residential, Inc.
(VRE) is the more profitable company, earning 26. 1% net margin versus 8. 8% for Welltower Inc. — meaning it keeps 26. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRE leads at 17. 1% versus 3. 3% for WELL. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VRE or WELL more undervalued right now?
Analyst consensus price targets imply the most upside for WELL: 4.
6% to $226. 50.
08Which pays a better dividend — VRE or WELL?
All stocks in this comparison pay dividends.
Veris Residential, Inc. (VRE) offers the highest yield at 1. 7%, versus 1. 3% for Welltower Inc. (WELL).
09Is VRE or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +233. 9% 10Y return). Both have compounded well over 10 years (WELL: +233. 9%, VRE: -12. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VRE and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VRE is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.